全球临床试验供应和物流市场规模、份额、趋势和成长分析报告（2026-2034）

临床试验供应和物流市场预计将从 2025 年的 481482 亿美元增长到 2034 年的 1005004 亿美元，2026 年至 2034 年的复合年增长率为 8.52%。

随着全球临床试验数量的增加，全球临床试验物资供应和物流市场正在迅速扩张。製药和生物技术公司正投入大量资金进行研发，以开发新药和疫苗并将其推向市场。临床试验材料的妥善储存、包装和运输至关重要，这推动了对专业物流服务的需求。

个人化医疗和生物製药的蓬勃发展进一步增加了临床试验的复杂性。对温度敏感的药品需要复杂的低温运输物流，这推动了对现代化供应链系统的投资。监管合规和严格的品质标准也是企业与专业物流供应商合作的重要因素。全球合作研究和多中心试验的增加也为进一步发展提供了支持。

未来，即时追踪和数据分析等数位技术将提升临床供应链的透明度和效率。分散式试验和居家参与的增加将催生新的物流需求。随着研究活动的拓展，新兴市场也预计将有重大贡献。整体而言，该市场具有强劲的长期成长潜力。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球临床试验供应与物流市场：依服务分类

• 市场分析、洞察与预测
• 物流/配送
• 储存/保留
• 包装、标籤和遮蔽
• 製造业
• 管制药物的采购
• 其他服务

第五章：全球临床试验供应与物流市场：依阶段划分

• 市场分析、洞察与预测
• 第一阶段
• 第二阶段
• 第三阶段
• 第四阶段

第六章：全球临床试验供应与物流市场：依治疗领域划分

• 市场分析、洞察与预测
• 肿瘤学
• 心血管疾病
• 呼吸系统疾病
• 中枢神经系统和精神障碍
• 其他的

第七章 全球临床试验供应与物流市场：依最终用途划分

• 市场分析、洞察与预测
• 製药
• 生物製药
• 医疗设备

第八章 全球临床试验供应与物流市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Thermo Fisher Scientific Inc
  • UPS Healthcare
  • Piramal Pharma Solutions
  • DHL
  • Parexel International
  • Almac Group
  • Movianto
  • UDG Healthcare
  • FedEx
  • Catalent Inc

The Clinical Trial Supply & Logistics Market size is expected to reach USD 10050.04 Million in 2034 from USD 4814.82 Million (2025) growing at a CAGR of 8.52% during 2026-2034.

The Global Clinical Trial Supply & Logistics Market is expanding rapidly due to the increasing number of clinical trials worldwide. Pharmaceutical and biotechnology companies are investing heavily in research and development to launch new drugs and vaccines. Proper storage, packaging, and transportation of clinical trial materials are critical, which drives demand for specialized logistics services.

The growth of personalized medicine and biologics has further increased the complexity of clinical trials. Temperature-sensitive drugs require advanced cold chain logistics, which has boosted investment in modern supply systems. Regulatory compliance and strict quality standards also push companies to partner with professional logistics providers. The rise in global collaborations and multi-center trials supports additional growth.

In the future, digital technologies such as real-time tracking and data analytics will enhance transparency and efficiency in clinical supply chains. The increasing use of decentralized trials and home-based participation will create new logistical needs. Emerging markets are also expected to contribute significantly as research activities expand. Overall, the market has strong long-term growth potential.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Service

• Logistics & Distribution
• Storage & Retention
• Packaging, Labeling, and Blinding
• Manufacturing
• Comparator Sourcing
• Other Services

By Phase

• Phase I
• Phase II
• Phase III
• Phase IV

By Therapeutic Area

• Oncology
• Cardiovascular Diseases
• Respiratory Diseases
• CNS and Mental Disorders
• Others

By End Use

• Pharmaceuticals
• Biologicals
• Medical Device

COMPANIES PROFILED

• Thermo Fisher Scientific Inc, UPS Healthcare, Piramal Pharma Solutions, DHL, Parexel International, Almac Group, Movianto, UDG Healthcare, FedEx, Catalent Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET: BY SERVICE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Service
• 4.2. Logistics & Distribution Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Storage & Retention Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Packaging, Labeling, and Blinding Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Manufacturing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Comparator Sourcing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Other Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET: BY PHASE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Phase
• 5.2. Phase I Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Phase II Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Phase III Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Phase IV Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET: BY THERAPEUTIC AREA 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Therapeutic Area
• 6.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Cardiovascular Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Respiratory Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. CNS and Mental Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET: BY END USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End Use
• 7.2. Pharmaceuticals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Biologicals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Medical Device Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Service
  • 8.2.2 By Phase
  • 8.2.3 By Therapeutic Area
  • 8.2.4 By End Use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Service
  • 8.3.2 By Phase
  • 8.3.3 By Therapeutic Area
  • 8.3.4 By End Use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Service
  • 8.4.2 By Phase
  • 8.4.3 By Therapeutic Area
  • 8.4.4 By End Use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Service
  • 8.5.2 By Phase
  • 8.5.3 By Therapeutic Area
  • 8.5.4 By End Use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Service
  • 8.6.2 By Phase
  • 8.6.3 By Therapeutic Area
  • 8.6.4 By End Use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Thermo Fisher Scientific Inc
  • 10.2.2 UPS Healthcare
  • 10.2.3 Piramal Pharma Solutions
  • 10.2.4 DHL
  • 10.2.5 Parexel International
  • 10.2.6 Almac Group
  • 10.2.7 Movianto
  • 10.2.8 UDG Healthcare
  • 10.2.9 FedEx
  • 10.2.10 Catalent Inc